Growing Incidences of Mental Disorders to Drive the Market
Injectable benzodiazepine drugs are administered as the first course of treatment with regards to mental disorders like depression, bipolar disorder, schizophrenia, dementia, anxiety disorder, autism.
The WHO, European Brain Council (EBC), and European College of Neuropsychopharmacology (ECNP) state that around 25% of the global population encounters mental disorders at least once in their lifetime.
As per NSDUH (National Survey on Drug Use and Health), in 2017, close to 46.6 million adults suffered from mental disorders (up by 1.5% in 2010) in the US. So, it could be inferred that 18-20% of the people in the US suffer from mental disorders, which are expected to account for the largest share of injectable benzodiazepines market in the forecast period.
As per the WHO, in the year 2017, around 35-40% of people in the EU were affected with mental disorders. Besides, as of 2015, increase in chronic depression resulted in higher absenteeism coupled with lower productivity at work. This lacuna had cost EU USD47.04 Billion Tn 2015.
On the other hand, India, in 2017, accounted for almost 15% of the global neurological, mental, and substance abuse disorders. In Asia-Pacific on the whole, more than 68% of the people are reported to have psychiatric disorders. This figure is expected to have Asia Pacific witness the highest growth rate in terms of injectable benzodiazepines.
As per the Anxiety and Depression Association of America, around 40 million adults of the US get affected by anxiety disorders every year. The medical fraternity states that the number of mental disorders would increase in the near future due to less attention being paid to self-talk.
All the facts mentioned above are expected to drive the injectable benzodiazepines market in the years to come.
Injectable benzodiazepine market is subject to fierce competition due to increasing adoption of generic injectables that prove to be cost-effective as compared to their branded counterparts. As per the Association of Accessible Medicines, branded drugs account for around 77% of the overall spending on prescriptions with merely 10% of those prescriptions getting filled.
Also, in the year 2017, generics saved close to USD 265 billion through generics. These generics corresponded to treatment for hypertension, ulcer, cholesterol, and mental health.
Generic diazepam, midazolam, and lorazepam drugs are prescribed for seizures, insomnia, and anxiety. These generic medications are expected to boost the injectable benzodiazepines market in the forecast period.
Injectable Benzodiazepines Market Remains Consolidated
The inorganic modes of expansion include technology and distribution agreements, product improvement, and partnerships. These moves are expected to give an impetus to the market in the forecast period.
For instance - Xeris Pharmaceuticals, in Apr 2020, announced positive results out of their Phase 1b weight-based dosing study regarding diazepam intramuscular (IM) injection by using XeriSol technology.
In Dec, 2019, Eton Pharmaceuticals, Inc. announced commercial availability of Biorphen, an injectable benzodiazepine, for treating hypotension.
“SUBLOCADE”, a buprenorphine extended-release injection, is available in the US since Mar 2018 post approval from the US FDA for treating OUD (opioid use disorder).
Short-Acting Injectable Benzodiazepines Gaining Traction
Increasing demand for short-acting injectable benzodiazepines due to faster excretion and immediate action is resulting in higher level of supervised administration.
Panic disorders are reported to affect around 2.7% of the US population. Muscle spasm and alcohol withdrawal also call for short acting injectable benzodiazepine drugs.
Plus, feasible scenario relating to reimbursement has made these healthcare solutions affable. These measures are expected to upscale the market in the forecast period.
Covid-19 Crisis to Bolster the Market Short-Term
The outbreak of Covid-19 has raised uncertainties, which have led to the onset of various mental disorders.
For instance - in Italy, the basic concern revolves around managing family and children along with maintenance of own borders and spaces. Developing economies like Brazil aren’t getting any active support on the count of addressing mental illnesses. Professional institutions need to come into picture to address this.
In the UK, the worrisome issues include uncertain future, anxiety/stress, and getting bored. Over 63% of the population of the UK is concerned about what is exactly in store for them. This factor is bound to raise the number of cases relating to mental stress.
In countries like India, almost 33% of the entire population has admitted to have a pessimistic impact of Covid-19 as joblessness has set in. Those working on daily wages and also the ones in field jobs have already lost out on their source of income; which is making inroads for depression and anxiety.
In the US, over 30% of people have been reported to get mentally affected by Covid-19. As the future looks bleak, people are getting drawn towards being mentally blank. Along with the professional concerns, there are personal concerns like coping up with the corporate lifestyle. A vacuum is getting created involuntarily; which is adding to the stress.
The factors mentioned above are expected to drive the market for injectable benzodiazepines in the next few months.
There only a handful of patented injectable benzodiazepines that fall in the “branded” category. As such, procuring and developing the ingredients could prove to be complex. Besides, stringent regulations regarding quality assessment may hamper the market.
Also, intake of these drugs without proper medical advice may prove to be fatal. Since the year 2010, overdose of benzodiazepines has resulted in 6507 deaths in the US. Also, in Sweden, a study was conducted wherein it was revealed that benzodiazepines are the drugs with majority of forged prescriptions.
This factor also proves to be a restraint with respect to the growth of the market.
Injectable Benzodiazepines Market: Region-wise Analysis
North America and Europe hold the largest market share in injectable benzodiazepines mainly due to increasing adoption of generic injectable benzodiazepines. The US is expected to witness around 2.8% growth in 2020. In Latin America, anxiety and alcohol withdrawal symptoms are driving the market and expected to do so in the forecast period as well.
Asia Pacific is witnessing mass production of generic injectable benzodiazepines, which will facilitate its fastest growth rate in the upcoming period. Oceania and MEA are still in the growth phase.
The injectable benzodiazepines market is in the consolidation phase; with 15+ players involved in extensive research and capacity expansion to maintain a strong foothold in the market.
One such study was conducted in Sweden in Apr 2020 to look into the association between paternal and maternal mental disorders with risk of injuries in the adolescents and children. On the similar grounds, a new study by Boston Medical Center revealed that 1 in 3 people receive medication related to opioid use disorder, that too, within a year of non-fatal overdose of the same. Likewise, studies are being conducted across the globe to look for advantages of injectable benzodiazepines and their application in the broader scenario.
The key players in the injectable benzodiazepines market include:
Americas
Europe
Asia Pacific
*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report
Injectable Benzodiazepines: The Way Forward
The injectable benzodiazepines market, in the long run, shows optimism, with FMI’s analysis predicting a steady growth rate of 2.7% in the forecast period. Covid-19 pandemic will also see an upswing in the market for the subsequent months. At the same time, growing adoption of generic drugs is another factor providing traction to the market.
The manufacturers are needed to emphasize on production and cost management for addressing drug shortages and also reach out to wider geographies. Auto-injector technology, if put into practice, is bound to reach more number of people within no time. Also, players will have to collaborate with the governments to reform the regulations; so that more such drugs could be tabled.
FMI’s study on the injectable benzodiazepines market offers information divided into three important segments - drug class, indication, time of action, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Table 01: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Drug Class
Table 02: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Indication
Table 03: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Time of Action
Table 04: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Distribution Channel
Table 05: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Region
Table 06: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 07: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class
Table 08: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication
Table 09: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action
Table 10: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel
Table 11: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 12: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class
Table 13: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication
Table 14: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action
Table 15: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel
Table 16: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 17: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class
Table 18: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication
Table 19: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action
Table 20: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel
Table 21: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 22: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class
Table 23: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication
Table 24: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action
Table 25: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel
Table 26: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 27: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class
Table 28: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication
Table 29: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action
Table 30: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel
Table 31: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 32: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class
Table 33: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication
Table 34: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action
Table 35: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel
Table 36: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 37: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class
Table 38: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication
Table 39: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action
Table 40: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel
Figure 01: Global Injectable Benzodiazepines Market Value Share, By Drug Class, 2019 (A)
Figure 02: Global Injectable Benzodiazepines Market Value Share, By Indication, 2019 (A)
Figure 03: Global Injectable Benzodiazepines Market Value Share, By Time of Action, 2019 (A)
Figure 04: Global Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2019 (A)
Figure 05: Global Injectable Benzodiazepines drugs Market Value Analysis 2015-2021 & 2030
Figure 06: Global Injectable Benzodiazepines drugs Market Y-O-Y Growth Analysis By Region
Figure 07: Global Injectable Benzodiazepines Drugs Market Value Analysis and Forecast, 2020–2030 (US$ Mn)
Figure 08: Global Injectable Benzodiazepines Drugs Market Absolute $ Opportunity (US$ Mn), 2015–2019
Figure 09: Global Injectable Benzodiazepines Drugs Market Absolute $ Opportunity (US$ Mn), 2020–2030
Figure 10: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Drug Class, 2020 & 2030
Figure 11: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Drug Class, 2020–2030
Figure 12: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020–2030
Figure 13: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Indication, 2020 & 2030
Figure 14: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Indication, 2020–2030
Figure 15: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020–2030
Figure 16: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Time of Action, 2020 & 2030
Figure 17: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Time of Action, 2020–2030
Figure 18: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020–2030
Figure 19: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Distribution Channel, 2020 & 2030
Figure 20: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Distribution Channel, 2020–2030
Figure 21: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020–2030
Figure 22: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Region, 2020 & 2030
Figure 23: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Region, 2020–2030
Figure 24: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Region, 2020–2030
Figure 25: North America Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019
Figure 26: North America Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030
Figure 27: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030
Figure 28: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030
Figure 29: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030
Figure 30: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030
Figure 31: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030
Figure 32: Latin America Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019
Figure 33: Latin America Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030
Figure 34: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030
Figure 35: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030
Figure 36: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030
Figure 37: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030
Figure 38: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030
Figure 39: Europe Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019
Figure 40: Europe Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030
Figure 41: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030
Figure 42: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030
Figure 43: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030
Figure 44: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030
Figure 45: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030
Figure 46: South Asia Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019
Figure 47: South Asia Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030
Figure 48: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030
Figure 49: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030
Figure 50: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030
Figure 51: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030
Figure 52: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030
Figure 53: East Asia Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019
Figure 54: East Asia Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030
Figure 55: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030
Figure 56: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030
Figure 57: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030
Figure 58: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030
Figure 59: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030
Figure 60: Oceania Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019
Figure 61: Oceania Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030
Figure 62: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030
Figure 63: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030
Figure 64: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030
Figure 65: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030
Figure 66: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030
Figure 67: MEA Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019
Figure 68: MEA Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030
Figure 69: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030
Figure 70: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030
Figure 71: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030
Figure 72: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030
Figure 73: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030
Figure 74: US Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 75: US Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 76: US Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 77: US Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 78: Canada Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 79: Canada Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 80: Canada Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 81: Canada Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 82: Australia Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 83: Australia Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 84: Australia Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 85: Australia Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 86: New Zealand Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 87: New Zealand Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 88: New Zealand Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 89: New Zealand Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 90: GCC Countries Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 91: GCC Countries Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 92: GCC Countries Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 93: GCC Countries Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 94: South Africa Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 95: South Africa Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 96: South Africa Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 97: South Africa Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 98: Turkey Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 99: Turkey Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 100: Turkey Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 101: Turkey Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 102: China Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 103: China Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 104: China Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 105: China Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 106: Japan Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 107: Japan Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 108: Japan Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 109: Japan Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 110: South Korea Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 111: South Korea Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 112: South Korea Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 113: South Korea Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 114: India Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 115: India Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 116: India Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 117: India Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 118: ASEAN Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 119: ASEAN Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 120: ASEAN Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 121: ASEAN Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 122: Germany Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 123: Germany Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 124: Germany Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 125: Germany Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 126: Italy Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 127: Italy Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 128: Italy Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 129: Italy Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 130: France Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 131: France Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 132: France Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 133: France Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 134: U.K. Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 135: U.K. Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 136: U.K. Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 137: U.K. Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 138: Spain Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 139: Spain Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 140: Spain Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 141: Spain Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 142: BENELUX Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 143: BENELUX Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 144: BENELUX Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 145: BENELUX Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 146: Russia Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 147: Russia Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 148: Russia Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 149: Russia Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 150: Brazil Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 151: Brazil Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 152: Brazil Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 153: Brazil Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
Figure 154: Mexico Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)
Figure 155: Mexico Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)
Figure 156: Mexico Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)
Figure 157: Mexico Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)
The injectable benzodiazepines market is expected to grow at a 2.7% CAGR from 2022 to 2032
By 2022-end, injectable benzodiazepines sales are likely to reach USD 274 Million
By 2032-end, injectable benzodiazepines sales are likely to reach USD 356Million
Pfizer Inc., Akorn Inc, and Sun Pharmaceutical Industries Limited are some leading injectable benzodiazepines market vendors.
Explore Pharmaceuticals Insights
Injectable Benzodiazepine Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
